Bradley McGregor

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Bradley McGregor
Feb 23, 2025, 01:54 | Blog
“Science in Seconds” with Bradley McGregor - ASCO
American Society of Clinical Oncology (ASCO) shared a post on LinkedIn: In our latest “Science…
Feb 13, 2025, 17:39 | Insight
Evaluating Treatment Options for High-Risk Renal Cell Cancer - Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology shared a post on X: "New Trial Alert! Bradley…
Jan 26, 2025, 06:40 | Insight
Highlights from AUC3 by Shilpa Gupta
The Advanced Urologic Cancer Consensus Conference (AUC3), held on January 23-24, 2025, was a dynamic…
Nov 10, 2024, 10:44 | Insight
Highlights from IKCSNA24: 20 Posts Not to Miss
The 2024 International Kidney Cancer Symposium: North America (IKCSNA24) held from November 7-9, 2024, at…
Sep 24, 2024, 12:30 | Societies
11 ESMO24 presentations published on NEJM
At the 2024 ESMO Congress, 11 articles were presented that were published in NEJM, highlighting…
Sep 17, 2024, 10:06 | Insight
Sumanta K. Pal: Important analysis of SWOG 1500 published just ahead of ESMO24
Sumanta K. Pal shared a post on X: "Huge congrats to Pedro C Barata, who drove…
Sep 15, 2024, 12:53 | Blog
Sumanta Pal's highlights from ESMO24
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Aug 4, 2024, 14:30 | Societies
8 Posts Not To Miss From GUWorld24!
The 2024 World Conference On Genitourinary Cancers (GUWorld24) took place from August 1st to 3rd…
Jul 14, 2024, 03:00 | Insight
Comprehensive talk on treatment options in adjuvant RCC by Bradley McGregor
Neeraj Agarwal shared on X: "Emerging treatment options in adjuvant RCC kidney cancer setting, comprehensive…
Jul 13, 2024, 12:22 | Insight
Key Highlights from KCRS24 by Sumanta K. Pal
Kidney Cancer Research Summit or the KCRS24 was a conference held on 11th-12th July in Boston focused…
Oct 12, 2023, 01:18 | Drugs
Guru P. Sonpavde: Are rational combinations of antibody-drug-conjugates a viable paradigm for future drug development?
Guru P. Sonpavde, Phase I and GU Oncology Director at Advent Health Cancer Institute, recently…
All: 11 Posts: 1 - 100
Special Coverage